Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-20 Sale |
2025-02-24 6:58 pm |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
1,016 | $61.19 | $62,168 | 62,053 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 9:24 pm |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
8,056 | $47.34 | $381,411 | 58,154 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-10 Option Award |
2025-01-14 4:30 pm |
N/A 2035-01-10 |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
67,938 | $0 | 113,684 (Direct) |
View |
| 2025-01-04 Tax Withholding |
2025-01-07 7:21 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
8,300 | $38.19 | 45,746 (Direct) |
View |
| 2025-01-06 Tax Withholding |
2025-01-07 7:21 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
2,284 | $38.86 | 45,746 (Direct) |
View |
| 2024-04-01 Tax Withholding |
2024-04-03 4:01 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
1,824 | $47.62 | 56,330 (Direct) |
View |
| 2024-01-05 Tax Withholding |
2024-01-08 9:06 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
2,507 | $37.96 | 141,210 (Direct) |
View |
| 2024-01-04 Option Award |
2024-01-08 9:06 pm |
N/A 2034-01-03 |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
101,445 | $0 | 141,210 (Direct) |
View |
| 2024-01-08 Tax Withholding |
2024-01-08 9:06 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
1,449 | $41.53 | 141,210 (Direct) |
View |
| 2023-04-03 Tax Withholding |
2023-04-05 4:46 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
1,375 | $25.25 | 43,721 (Direct) |
View |
| 2023-01-06 Tax Withholding |
2023-01-09 5:00 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
1,665 | $27.52 | 115,096 (Direct) |
View |
| 2023-01-05 Option Award |
2023-01-09 5:00 pm |
N/A 2033-01-05 |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
92,663 | $0 | 115,096 (Direct) |
View |
| 2022-04-01 Tax Withholding |
2022-10-13 4:03 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
1,464 | $56.9 | 124,098 (Direct) |
View |
| 2022-10-11 Option Award |
2022-10-13 4:03 pm |
N/A 2032-10-11 |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
100,000 | $0 | 124,098 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 4:23 pm |
N/A 2032-01-06 |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
53,772 | $0 | 66,272 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-01 5:37 pm |
N/A 2031-04-01 |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
104,500 | $0 | 104,500 (Direct) |
View |